MD/PhD, Stanford University
I am a neurosurgery resident at the University of Toronto. In 2012 I left residency to pursue a PhD in developmental neurobiology at Stanford University. While at Stanford I entered a highly interdisciplinary project aimed at identifying novel drug targets for pediatric brain cancer. Ultimately, this led to a clinical trial for a promising new drug for the treatment of medulloblastoma, the most common pediatric brain cancer, which is planned to begin winter 2018.
I am a graduate student and resident in the field of neurosurgery and would like to share an unusual and very personal story of developing a drug. Developmental biologist Dr. Matthew Scott and I went from purely basic...